Saluda Medical Statistics

Total Valuation

Saluda Medical has a market cap or net worth of AUD 365.43 million. The enterprise value is 1.18 billion.

Market Cap	365.43M
Enterprise Value	1.18B

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

Saluda Medical has 252.02 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	252.02M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	2.30%
Owned by Institutions (%)	29.02%
Float	56.29M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	3.41
PB Ratio	-2.27
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-5.20
EV / Sales	11.03
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-6.49

Financial Position

The company has a current ratio of 0.75

Current Ratio	0.75
Quick Ratio	0.43
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	-1.72
Interest Coverage	-4.33

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-57.64%
Return on Invested Capital (ROIC)	-73.26%
Return on Capital Employed (ROCE)	418.67%
Revenue Per Employee	806,872
Profits Per Employee	-1.71M
Employee Count	133
Asset Turnover	0.55
Inventory Turnover	1.04

Taxes

In the past 12 months, Saluda Medical has paid 806,884 in taxes.

Income Tax	806,884
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	18.98
Average Volume (20 Days)	817,357

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Saluda Medical had revenue of AUD 107.31 million and -227.73 million in losses. Loss per share was -1.36.

Revenue	107.31M
Gross Profit	49.96M
Operating Income	-180.06M
Pretax Income	-226.92M
Net Income	-227.73M
EBITDA	-177.55M
EBIT	-180.06M
Loss Per Share	-1.36

Full Income Statement

Balance Sheet

The company has 83.13 million in cash and 312.86 million in debt, giving a net cash position of -229.73 million or -0.91 per share.

Cash & Cash Equivalents	83.13M
Total Debt	312.86M
Net Cash	-229.73M
Net Cash Per Share	-0.91
Equity (Book Value)	-160.98M
Book Value Per Share	-4.47
Working Capital	-60.32M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -180.35 million and capital expenditures -1.94 million, giving a free cash flow of -182.29 million.

Operating Cash Flow	-180.35M
Capital Expenditures	-1.94M
Free Cash Flow	-182.29M
FCF Per Share	-0.72

Full Cash Flow Statement

Margins

Gross margin is 46.56%, with operating and profit margins of -167.79% and -212.21%.

Gross Margin	46.56%
Operating Margin	-167.79%
Pretax Margin	-211.46%
Profit Margin	-212.21%
EBITDA Margin	-165.45%
EBIT Margin	-167.79%
FCF Margin	n/a

Dividends & Yields

Saluda Medical does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-62.32%
FCF Yield	-49.88%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Saluda Medical has an Altman Z-Score of -9.1 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-9.1
Piotroski F-Score	1